Indian Army Eye Care Medicines & Topical Products Tender Hyderabad Telangana 2025

Tender Overview

The Indian Army, Department Of Military Affairs, seeks a supply-only tender for a range of eye care, dermatological, and nasal/respiratory products to be delivered at Hyderabad, Telangana. The list includes Latanoprost 0.005% with Timolol 0.5% eye drop (2.5 ml), Ciprofloxacin eye ointment (various strengths), nasal decongestants, budesonide/formoterol inhalation, Minoxidil topical solution, benzoyl peroxide ointment, betamethasone dipropionate with gentamicin, hydroquinone cream, terbinafine cream, cut-to-size glucometer test strips (25 per bottle). The tender notes a total of 10 items in the BOQ but provides no item-level quantities. The scope is clearly stated as “Only supply of Goods” with no installation or after-sales service required. The Buyer reserves a 25% quantity variation during order placement and again during contract continuity, with delivery timelines calculated from the last delivery order date and minimum 30 days for any extended period. This procurement targets medical and topical pharmaceuticals with emphasis on standardization across items and uniform delivery. The geographic focus is Hyderabad, Telangana, and the packaging quantities/volumes align to standard pharmaceutical formats. The tender emphasizes compliance with delivery schedules and option-based quantity adjustments, highlighting the need for robust logistics and accurate stock forecasting. This is a pure supply contract with no service components.

Technical Specifications & Requirements

• Product categories include: ophthalmic solutions (latanoprost + timolol), ophthalmic ointments (ciprofloxacin), nasal decongestants (xylometazoline), inhaled corticosteroids (budesonide/formoterol), topical dermatology (minoxidil, benzoyl peroxide, betamethasone/gentamicin, hydroquinone, terbinafine), and glucose test strips.
• No explicit numeric specifications or standard codes provided in the data; item-level quantities are not disclosed in the BOQ.
• The scope is limited to “Only supply of Goods,” implying procurement of finished pharmaceutical products and topical preparations that meet general pharmaceutical manufacturing standards.
• The tender includes a quantity flex clause up to 25% during order placement and during the currency of the contract, requiring bidders to plan for scalable stock and adaptable logistics.
• The delivery period mechanism is described as commencing from the last date of the original delivery order, with a minimum 30-day increase and potential extension up to the original delivery period.
• No warranty, testing, or certification specifics are listed in the provided data.
• Special terms emphasize bidder compliance with the option clause and delivery scheduling, indicating a focus on reliable supply chain performance.

Terms, Conditions & Eligibility

• EMD details: Not specified in the provided data.
• Quantity adjustment rights: 25% increase/decrease at time of order; 25% during currency with contracted rates.
• Delivery: Calculated using the option clause; minimum 30 days extension if quantity increases; starts from last delivery order date.
• Payment terms: Not disclosed in the supplied information.
• Documents required: Not specified; bidders should anticipate GST, PAN, experience certificates, financial statements, and EMD documentation per standard government tenders.
• Scope: Supply of Goods only; no installation, commissioning, or aftersales service mentioned.
• Eligibility criteria: Not explicitly stated; bidders should prepare to demonstrate capacity for pharmaceutical supply and logistics, with potential compliance to relevant drug regulatory standards.
• Penalties: Not described in the given terms; bidders should seek clarification on LDs or performance bonds in the final offer.